Filter Results
:
(7,932)
Show Results For
-
All HBS Web
(7,932)
- People (21)
- News (2,550)
- Research (4,039)
- Events (18)
- Multimedia (276)
- Faculty Publications (3,288)
Show Results For
-
All HBS Web
(7,932)
- People (21)
- News (2,550)
- Research (4,039)
- Events (18)
- Multimedia (276)
- Faculty Publications (3,288)
- November 2016
- Case
QuintilesIMS: Biosimilar Marketing in England
By: John A. Quelch and Emily C. Boudreau
QuintilesIMS was a leading healthcare consulting firm best known for its data and information offerings as well as its market research and management consulting services for life science companies. By 2015, the company was expanding beyond the biopharmaceutical...
View Details
Keywords:
Health;
Pharmaceutical Industry;
Biotech;
Marketing;
Health Care and Treatment;
Biotechnology Industry;
England
Quelch, John A., and Emily C. Boudreau. "QuintilesIMS: Biosimilar Marketing in England." Harvard Business School Case 517-054, November 2016.
- June 2015 (Revised November 2016)
- Case
HealthCare.gov: The Crash and the Fix (A)
By: Leonard A. Schlesinger and Paras D. Bhayani
A review of the process utilized by the Obama administration to create the Health Care.gov exchange and the problems that resulted from the implementation effort. There is a B case that provides the follow on strategy and processes utilized to get the site up and...
View Details
Keywords:
Organizational Change;
Implementing Strategy;
Implementation;
Government Innovation;
Health Care Industry;
Health Care Reform;
Health Care and Treatment;
Government Administration;
Governing Rules, Regulations, and Reforms;
Organizational Change and Adaptation;
Health Industry;
Health Industry;
United States
Schlesinger, Leonard A., and Paras D. Bhayani. "HealthCare.gov: The Crash and the Fix (A)." Harvard Business School Case 315-129, June 2015. (Revised November 2016.)
- June 2015 (Revised November 2016)
- Supplement
HealthCare.gov: The Crash and the Fix (B)
By: Leonard A. Schlesinger and Paras D. Bhayani
A review of the process utilized by the Obama administration to create the Health Care.gov exchange and the problems that resulted from the implementation effort. This case provides the follow on strategy and processes utilized to get the site up and running after the...
View Details
Keywords:
Organizational Change;
Implementing Strategy;
Implementation;
Government Innovation;
Health Care Industry;
Health Care Reform;
Service Delivery;
Internet and the Web;
Health;
Government and Politics;
Health Industry;
Health Industry;
Health Industry;
United States
Schlesinger, Leonard A., and Paras D. Bhayani. "HealthCare.gov: The Crash and the Fix (B)." Harvard Business School Supplement 315-130, June 2015. (Revised November 2016.)
- 17 Aug 2021
- Blog Post
Applying the MBA Skillset to Global Health Challenges: Summer Fellow Vasilis Theodorou (MBA 2022)
are working around the world to develop skills and knowledge while having significant responsibility and high impact. What are you working on this summer? I am working at Clinton Health Access Initiative, Inc (CHAI), a global View Details
- April 18, 2022
- Article
Will mRNA Technology Companies Spawn Innovation Ecosystems?
By: Christoph Grimpe, Timo Minssen, W. Nicholson Price, II and Ariel Dora Stern
The mRNA technologies that helped rapidly create effective COVID-19 vaccines could become technology platform businesses, which has tremendous implications for players in the world of drug development. These platforms could attract other companies interested in...
View Details
Keywords:
Health Care;
Digital Health;
Technology;
Innovation;
Health Care and Treatment;
Technological Innovation;
Digital Transformation;
Health Industry;
United States
Grimpe, Christoph, Timo Minssen, W. Nicholson Price, II, and Ariel Dora Stern. "Will mRNA Technology Companies Spawn Innovation Ecosystems?" Harvard Business Review (website) (April 18, 2022).
- 2022
- Article
Investigating the Association Between Telemedicine Use and Timely Follow-Up Care After Acute Cardiovascular Hospital Encounters
By: Mitchell Tang, A Jay Holmgren, Erin E. McElrath, Ankeet S. Bhatt, Anubodh S. Varshney, Simin Gharib Lee, Muthiah Vaduganathan, Dale S. Adler and Robert S. Huckman
Background: Telemedicine use increased dramatically during the COVID-19 pandemic; however, questions remain as to how telemedicine use impacts care.
Objectives: The purpose of this study was to examine the association of increased telemedicine use on rates of... View Details
Objectives: The purpose of this study was to examine the association of increased telemedicine use on rates of... View Details
Keywords:
Health Care;
Telemedicine;
Health Care and Treatment;
Outcome or Result;
Behavior;
Health Industry;
United States
Tang, Mitchell, A Jay Holmgren, Erin E. McElrath, Ankeet S. Bhatt, Anubodh S. Varshney, Simin Gharib Lee, Muthiah Vaduganathan, Dale S. Adler, and Robert S. Huckman. "Investigating the Association Between Telemedicine Use and Timely Follow-Up Care After Acute Cardiovascular Hospital Encounters." JACC: Advances 1, no. 5 (2022).
- September 2013 (Revised October 2016)
- Background Note
A Note on Healthcare IT and Applications to the Healthcare Industry
By: Robert F. Higgins and Diana Maichin
This note provides an overview of three key healthcare IT areas: electronic medical records and electronic health records, revenue cycle management, and telemedicine. This note also contains a glossary of key terms and acronyms in this space as well as exhibits...
View Details
Keywords:
Health Care;
Health Care Industry;
Healthcare IT;
Healthcare;
Healthcare Technology;
Healthcare Ventures;
Electronic Medical Records;
Electronic Health Records;
Revenue Cycle Management;
Telemedicine;
Health;
Health Care and Treatment;
Information Technology;
Information Management;
Health Industry;
Health Industry;
United States
Higgins, Robert F., and Diana Maichin. "A Note on Healthcare IT and Applications to the Healthcare Industry." Harvard Business School Background Note 814-033, September 2013. (Revised October 2016.)
- Article
More Insurers, Lower Premiums: Evidence from Initial Pricing in the Health Insurance Marketplaces
By: Leemore S. Dafny, Jonathan Gruber and Christopher Ody
Dafny, Leemore S., Jonathan Gruber, and Christopher Ody. "More Insurers, Lower Premiums: Evidence from Initial Pricing in the Health Insurance Marketplaces." American Journal of Health Economics 1, no. 1 (Winter 2015): 53–81.
- 2017
- Chapter
The Private Provision of Missing Public Goods: Evidence from Narayana Health in India
By: Tarun Khanna and Budhaditya Gupta
Khanna, Tarun, and Budhaditya Gupta. "The Private Provision of Missing Public Goods: Evidence from Narayana Health in India." Chap. 3 in India as a Pioneer of Innovation, edited by Harbir Singh, Ananth Padmanabhan, and Ezekiel Emanuel. Oxford University Press, 2017.
- April 2021
- Case
ClearChoice Dental Implant Centers
By: Robert S. Kaplan, Ashiana Jivraj and Jane Barrow
The case illustrates the application of value-based health care to dental medicine. ClearChoice Dental Implant Centers was a rapidly-growing network of dentist-owned independent implant clinics. The targeted market included 23 million people, 15% of the US adult...
View Details
Keywords:
Value-based Health Care;
Dental Medicine;
Growth and Development Strategy;
Expansion;
Business Strategy;
Customer Value and Value Chain;
Customer Focus and Relationships;
Health Industry;
United States
Kaplan, Robert S., Ashiana Jivraj, and Jane Barrow. "ClearChoice Dental Implant Centers." Harvard Business School Case 121-082, April 2021.
- April 2012
- Article
Paying a Premium on Your Premium? Consolidation in the U.S. Health Insurance Industry
By: Leemore S. Dafny, Mark Duggan and Subramaniam Ramanarayanan
Dafny, Leemore S., Mark Duggan, and Subramaniam Ramanarayanan. "Paying a Premium on Your Premium? Consolidation in the U.S. Health Insurance Industry." American Economic Review 102, no. 2 (April 2012): 1161–1185.
- Article
Ten Year Sunset Rule for Healthcare Regulation Is a Nonstarter and Discouragement to Post-COVID-19 Investment
By: Regina E. Herzlinger and Eugene Schneller
U.S. healthcare delivery has not benefitted from the same productivity growth as many other service industries, such as bricks and mortar retailing, a loss that has gravely diminished cost control and access. Regulatory capture, which creates barriers to venture...
View Details
Keywords:
Health Care;
COVID-19;
Regulation;
Health Care and Treatment;
Health Pandemics;
Governing Rules, Regulations, and Reforms;
Investment
Herzlinger, Regina E., and Eugene Schneller. "Ten Year Sunset Rule for Healthcare Regulation Is a Nonstarter and Discouragement to Post-COVID-19 Investment." Journal of Health Care Finance 47, no. 4 (Spring 2021). (Special Commentary.)
- Web
Bringing the Next Pandemic Vaccine to Your Doorstep with MIMIX - Blog: Health Supplement
Blog Blog Health Supplement Filter Results Arrow Down Arrow Up Read posts from Author Alumni Author Blavatnik Fellow Author Blavatnik Fellowship Team Author Executive Education Author HBS Partners Author HBS Staff Author View Details
- April 2017
- Teaching Note
CV Ingenuity (A) and (B)
Teaching Note for HBS Nos. 315-045 and 315-087.
View Details
- 08 Nov 2021
- Blog Post
4 Ways the MS/MBA is Preparing Me for a Career in Health Care and the Life Sciences
health care value chain in Israel and Western Europe, an experience that culminated in supporting the COVID-19 vaccine response as part of the McKinsey Social Sector Hub in Geneva. Why the MS/MBA Biotechnology: Life Sciences degree?...
View Details
- November 2022 (Revised December 2022)
- Exercise
Choose Your Own Adventure: Your Financial Health (A): Congratulations, HBS Grad! Now, What?
By: Sara Fleiss and Emily R. McComb
Fleiss, Sara, and Emily R. McComb. "Choose Your Own Adventure: Your Financial Health (A): Congratulations, HBS Grad! Now, What?" Harvard Business School Exercise 223-043, November 2022. (Revised December 2022.)
- March 2015 (Revised January 2024)
- Case
CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen (HBS MBA ’01) hoped to win over a prominent venture capital investor for Series B financing of his firm CVI that was creating a drug-eluting balloon (DES) to treat peripheral arterial disease. As a second-mover, Duke felt he was more likely to acquire...
View Details
Keywords:
CV Ingenuity;
CVI;
Drug Eluting Balloon;
DEB;
Drug Eluting Stent;
Angioplasty Balloon;
FoxHollow;
Medical Device;
Medical Device Startup;
Premarket Approval;
PMA;
Lutonix;
Stellarex;
LEVANT;
ILLUMENATE;
Clinical Trials;
Peripheral Arterial Disease;
PAD;
Healthcare Startups;
Covidien;
Health Care and Treatment;
Health Testing and Trials;
Business Startups;
Commercialization;
Health Industry;
Health Industry;
United States;
Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies." Harvard Business School Case 315-045, March 2015. (Revised January 2024.)
- February 2021
- Case
New England Baptist Hospital: Getting Paid for Value
By: Robert S. Kaplan, Mary Witkowski, Toby E. Emanuel and Syed S. Shehab
New England Baptist Hospital (NEBH), a national leader in adult orthopedic care, has the lowest rate of complications and 30-day readmissions in New England, but gets paid 30% less for its surgeries than nearby institutions. NEBH introduces, with several large...
View Details
Keywords:
Healthcare;
Healthcare Spending;
Healthcare Innovation;
Healthcare Industry;
Health Care Outcomes;
Health Care Delivery;
Health Care Reform;
Bundled Payments;
Health Care and Treatment;
Spending;
Innovation and Invention;
Value Creation;
Strategy;
Health Industry;
North America
Kaplan, Robert S., Mary Witkowski, Toby E. Emanuel, and Syed S. Shehab. "New England Baptist Hospital: Getting Paid for Value." Harvard Business School Case 121-036, February 2021.